Working Life: Celgene’s Rob Moore
July 14, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene, Working Life, rob moore
How did you find your way into your current role? I joined the pharmaceutical industry almost 20 years ago with …
ProStrakan pays £230m for Archimedes
July 14, 2014Sales and Marketing Archimedes, Cancer, ProStrakan, pain, pecfent
The ProStrakan Group is to looking to expand its offerings via a payment of £230 million for Archimedes Pharma. The …
Two hires at Cello Health Communications
July 14, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cello, cello health, davies, yates
Healthcare comms agency Cello Health Communications has made two senior appointments at its London office. Anthea Davies (pictured) joins the …
Bayer in Oxford tie-up
July 11, 2014Research and Development, Sales and Marketing Bayer, Oxford, endometriosis, university
Bayer HealthCare and the UK’s University of Oxford have signed an agreement to look for new treatments for two common …
BMS to make Opdivo submission
July 11, 2014Sales and Marketing BMS, Cancer, EMA, FDA, ono, opdivo, pd-1
Bristol-Myers Squibb is to submit cancer treatment Opdivo to the US authorities after the drug received its first approval in …
QRxPharma announces several resignations
July 11, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Campbell, PACE, QRxPharma, farrell, quinn
Australian pharma development firm QRxPharma has confirmed that its chairman Dr Peter Farrell and director Dr Gary Pace have resigned. …
Servier fined €331m by European Commission
July 10, 2014Sales and Marketing EC, European Commission, France, Krka, Lupin, Matrix, Mylan, Niche/Unichem, Servier, Teva
The European Commission has served French pharma company Servier with a €331 million fine for delaying the entry to market …
EMA delays trial transparency – again
July 10, 2014Medical Communications, Research and Development, Sales and Marketing EMA, Goldacre, Rasi, alltrials, clinical trials, transparency
The European Medicines Agency has once again said that it is to delay the launch of its new clinical trial …
NICE ‘yes’ for Selincro
July 10, 2014Sales and Marketing Lundbeck, NHS, NICE, alcohol, nalmefene, selincro
Lundbeck has received a lift from UK drugs pricing watchdog NICE as it has recommended the firm’s alcohol dependency pill …
Glide Pharma makes two senior hires
July 10, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Glide Pharma, Richard Bungay, Tony Mills
Oxford-based development and device firm Glide Pharma has appointed Richard Bungay as its chief financial officer (CFO) and Dr Tony …
Alzheimer’s test ‘87% accurate’, say reports
July 9, 2014Sales and Marketing Alzheimer's, Alzheimer’s, Alzheimer’s & dementia, Cameron, NHS, NHS Choices, dementia
NHS Choices has dampened enthusiasm over a report in medical journal Alzheimer’s & Dementia of a new test for Alzheimer’s …
Celebrities back Bowel Cancer UK’s screening call
July 9, 2014Medical Communications, Sales and Marketing bowel cancer uk, celebrities, screening
A range of celebrities, including Sir Chris Hoy, Benedict Cumberbatch, Ricky Gervais and Ben Richards, have pledged support to Bowel …
Lucid opens second office
July 9, 2014Medical Communications CME, lucid
UK medical education firm Lucid has opened a second office in Hammersmith, London. In addition to Lucid Towers, Beaconsfield, it now …
Boehringer blood cancer drug scores in Phase II
July 9, 2014Research and Development, Sales and Marketing Boehringer, blood, giotrif, leukaemia, volasertib
Less than a year after securing its first cancer drug on the market with Giotrif, Boehringer has taken another decisive …
AbbVie makes fourth Shire offer
July 9, 2014Sales and Marketing AbbVie, Abbott, Shire, buyout, merger
The AbbVie/Shire takeover saga rumbles on, with AbbVie raising its bid for the Ireland-based biopharma specialist to $51.5 billion. The …
Clark Health Communications hires account director
July 9, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Clark Health Communications, chc, newman
Clark Health Communications (CHC) has recruited account director Sarah Newman as its first full-time employee to help manage the agency’s …
Telemedicine EU market ‘expected to triple’ by 2020
July 8, 2014Medical Communications, Sales and Marketing Europe, Frost & Sullivan, analysts, telemedicine
The telemedicine market in Europe is poised for rapid growth and can help keep overall healthcare costs down, according to …
UDG Healthcare buys Galliard and Nyxeon for £13m
July 8, 2014Medical Communications Galliard and Nyxeon, udg healthcare
UDG Healthcare has acquired the specialist healthcare and scientific public relations businesses Galliard and Nyxeon. The deal has been secured …
Cameron’s antibiotics plan not enough
July 8, 2014Research and Development, Sales and Marketing Antibiotics, BBC, NHS, UK, david cameron, governement
UK prime minister David Cameron’s reaction to antibiotic resistance is not urgent enough and doctors are continuing to prescribe antibiotics …
World’s first anti-PD-1 therapy approved
July 8, 2014Research and Development, Sales and Marketing BMS, Cancer, melanoma, nivolumab, ono, opdivo
Ono Pharmaceutical has been given the world’s first licence for a new type of cancer treatment on which many researchers’ …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
